Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
Want to see AAPG full AI Analyst Report?
Total Valuation
Ascentage Pharma Group International Unsponsored ADR has a market cap or net worth of $1.91B. The enterprise value is $12.78B.
Market Cap$1.91B
Enterprise Value$12.78B
Share Statistics
Ascentage Pharma Group International Unsponsored ADR has 93,333,690 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding93,333,690
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ascentage Pharma Group International Unsponsored ADR’s return on equity (ROE) is -0.91 and return on invested capital (ROIC) is -33.26%.
Return on Equity (ROE)-0.91
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-33.26%
Return on Capital Employed (ROCE)-0.51
Revenue Per Employee984.97K
Profits Per Employee-2.18M
Employee Count567
Asset Turnover0.14
Inventory Turnover4.60
Valuation Ratios
The current PE Ratio of Ascentage Pharma Group International Unsponsored ADR is ―. Ascentage Pharma Group International Unsponsored ADR’s PEG ratio is -0.09.
PE Ratio―
PS Ratio29.25
PB Ratio12.33
Price to Fair Value12.33
Price to FCF-13.59
Price to Operating Cash Flow-16.95
PEG Ratio-0.09
Income Statement
In the last 12 months, Ascentage Pharma Group International Unsponsored ADR had revenue of 558.48M and earned -1.21B in profits. Earnings per share was -13.56.
Revenue558.48M
Gross Profit426.75M
Operating Income-1.18B
Pretax Income-1.20B
Net Income-1.21B
EBITDA-1.10B
Earnings Per Share (EPS)-13.56
Cash Flow
In the last 12 months, operating cash flow was -779.66M and capital expenditures -7.75M, giving a free cash flow of -787.41M billion.
Operating Cash Flow-779.66M
Free Cash Flow-787.41M
Free Cash Flow per Share-8.44
Dividends & Yields
Ascentage Pharma Group International Unsponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change-20.66%
50-Day Moving Average37.24
200-Day Moving Average―
Relative Strength Index (RSI)34.89
Average Volume (3m)8.43K
Important Dates
Ascentage Pharma Group International Unsponsored ADR upcoming earnings date is Aug 26, 2026, TBA (Confirmed).
Last Earnings DateMar 25, 2026
Next Earnings DateAug 26, 2026
Ex-Dividend Date―
Financial Position
Ascentage Pharma Group International Unsponsored ADR as a current ratio of 1.79, with Debt / Equity ratio of 149.47%
Current Ratio1.79
Quick Ratio1.77
Debt to Market Cap0.12
Net Debt to EBITDA0.45
Interest Coverage Ratio-22.42
Taxes
In the past 12 months, Ascentage Pharma Group International Unsponsored ADR has paid 6.75M in taxes.
Income Tax6.75M
Effective Tax Rate>-0.01
Enterprise Valuation
Ascentage Pharma Group International Unsponsored ADR EV to EBITDA ratio is -14.47, with an EV/FCF ratio of -13.19.
EV to Sales28.37
EV to EBITDA-14.47
EV to Free Cash Flow-13.19
EV to Operating Cash Flow-13.50
Balance Sheet
Ascentage Pharma Group International Unsponsored ADR has $2.47B in cash and marketable securities with $1.98B in debt, giving a net cash position of $490.68M billion.
Cash & Marketable Securities$2.47B
Total Debt$1.98B
Net Cash$490.68M
Net Cash Per Share$5.26
Tangible Book Value Per Share$13.98
Margins
Gross margin is 84.09%, with operating margin of -211.14%, and net profit margin of -216.47%.
Gross Margin84.09%
Operating Margin-211.14%
Pretax Margin-215.29%
Net Profit Margin-216.47%
EBITDA Margin-196.08%
EBIT Margin-211.14%
Analyst Forecast
The average price target for Ascentage Pharma Group International Unsponsored ADR is $41.56, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$41.56
Price Target Upside51.67% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast-41.19%
EPS Growth Forecast-159.09%